Site Map

Radiation therapy - skin care

I Would Like to Learn About:

Description

When you have radiation treatment for cancer, you may have some changes in your skin in the area being treated. Your skin may turn red, peel, or itch. You should treat your skin with care while receiving radiation therapy.

Causes

External radiation therapy uses high-powered radiation or particles to kill cancer cells. The radiation rays or particles are aimed directly at the tumor from outside of the body. Radiation therapy also damages or kills healthy cells. During treatment, skin cells do not have enough time to grow back between radiation sessions. This causes side effects.

Skin Side Effects

Side effects depend on the dose of radiation, how often you have the therapy, and the part of your body the radiation is focused on, such as:

Two weeks or so after radiation treatment starts, you may notice skin changes such as:

Most of these symptoms will go away after your treatments have stopped. However, your skin may remain darker, drier, and more sensitive to the sun. When your hair grows back, it may be different than before.

Skin Care

When you have radiation treatment, a health care provider tattoos small permanent marks on your skin. These indicate where to aim the radiation.

Take care of the skin in the treatment area.

Keep the treatment area out of direct sunlight while undergoing treatment.

The treated area will be more sensitive to the sun. You will also be more at risk for skin cancer in that area. Tell your provider if you have skin changes and any break or openings in your skin.

References

Doroshow JH. Approach to the patient with cancer. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 169.

National Cancer Institute website. Radiation therapy and you: support for people with cancer. www.cancer.gov/publications/patient-education/radiationttherapy.pdf. Updated October 2016. Accessed July 1, 2022.

Zeman EM, Schreiber EC, Tepper JE. Basics of radiation therapy. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 27.

BACK TO TOP

Review Date: 4/29/2022  

Reviewed By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

ADAM Quality Logo
Health Content Provider
06/01/2025

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complied with the HONcode standard for trustworthy health information from 1995 to 2022, after which HON (Health On the Net, a not-for-profit organization that promoted transparent and reliable health information online) was discontinued.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2024 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.